Cite
APA Citation
Lüftner, D., Tesch, H., Schmidt, M., Hartkopf, A., Streicher, S., Resch, A., Genovese, L., Rosé, C., Valenti, R., & Harbeck, N. (n.d.). neratinib as extended adjuvant therapy in patients with HER2-positive/HR-positive early breast cancer: German HTA-driven analyses from the ExteNET study. Breast, 56, S17–. http://access.bl.uk/ark:/81055/vdc_100123996175.0x000030